menu
    • menu

    Company profile for Ionis Pharmaceuticals

    NEW Drugs in Dev: 66
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are the leading company in RNA-targeted drug discovery and development with a pipeline of first-in-class or best-in-class medicines with the potential to provide high value for patients with significant unmet medical needs. We have created an efficient and broadly applicable drug discovery platform. Using this platform, we believe that we are revolutionizing medicine with the goal to improve the quality of, and save, lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ionis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2855 Gazelle Court Carlsbad, CA 92010
    Telephone
    Telephone
    760-931-9200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ionispharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ionis-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ionispharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ionis partner Biogen Announces Results from Phase 2 CELIA study
    Ionis partner Biogen Announces Results from Phase 2 CELIA study

    14 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260514986673/en/Ionis-partner-Biogen-announces-topline-results-from-Phase-2-CELIA-study-of-diranersen-BIIB080-first-study-to-show-reduction-in-tau-pathology-and-cognitive-benefit-in-patients-with-early-Alzheimers-disease

    BUSINESSWIRE
    14 May 2026
    Share Share
    Ionis to Host 2026 Virtual Annual Meeting of Stockholders
    Ionis to Host 2026 Virtual Annual Meeting of Stockholders

    04 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260504500537/en/Ionis-to-host-2026-virtual-Annual-Meeting-of-Stockholders

    BUSINESSWIRE
    04 May 2026
    Share Share
    Ionis Reports Q1 2026 Results and Key Program Updates
    Ionis Reports Q1 2026 Results and Key Program Updates

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260429109051/en/Ionis-reports-first-quarter-2026-financial-results-and-highlights-progress-on-key-programs

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    GSK's Bepirovirsen Gets FDA Priority Review for Hepatitis B
    GSK's Bepirovirsen Gets FDA Priority Review for Hepatitis B

    28 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260427721143/en/Ionis-partner-GSK-announces-bepirovirsen-accepted-for-Priority-Review-and-granted-Breakthrough-Therapy-Designation-by-U.S.-FDA-as-a-potential-first-in-class-medicine-for-chronic-hepatitis-B

    BUSINESSWIRE
    28 Apr 2026
    Share Share
    Ionis Antisense Drug Stabilizes Ultra-Rare Disease Before FDA
    Ionis Antisense Drug Stabilizes Ultra-Rare Disease Before FDA

    22 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/ionis-antisense-drug-stabilizes-ultra-rare-disease-ahead-of-fda-decision

    BIOSPACE
    22 Apr 2026
    Share Share
    Ionis Shares Pivotal Zilganersen Data in Alexander Disease
    Ionis Shares Pivotal Zilganersen Data in Alexander Disease

    21 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260421814919/en/Ionis-presents-new-data-from-pivotal-study-of-zilganersen-in-Alexander-disease-AxD-at-AAN-2026-Annual-Meeting

    BUSINESSWIRE
    21 Apr 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ionis Pharmaceuticals and get a quotation

    Ionis Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Nusinersen bulk offered by Ionis Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search